NMPA Approval

Olmesartan Medoxomil and Amlodipine Besylate Tablets

Approval Number

国药准字H20254170

Company珠海润都制药股份有限公司

Registration Date

May 13, 2025

Drug Information

Generic Name

奥美沙坦酯氨氯地平片

Dosage Form

片剂

Strength

每片含奥美沙坦酯20mg和苯磺酸氨氯地平5mg（按 C₂₀H₂₅ClN₂O₅计）

Drug Type

化学药品

Registration Date

May 13, 2025

Company Information

Applicant Company

Company Name珠海润都制药股份有限公司

Company Address

珠海市金湾区三灶镇机场北路6号

Manufacturing Company

Company Name珠海润都制药股份有限公司

Company Address

珠海市金湾区三灶镇机场北路6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

奥美沙坦酯氨氯地平片 - NMPA 批准文号 | MedPath